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SUMMARY
Despite the effectiveness of combination antiretroviral therapy in the treatment of people living with HIV/AIDS (PLWHA), 
nonadherence to medication has become a major threat to its effectiveness. This study aimed to estimate the prevalence of self-reported 
irregular use of antiretroviral therapy and the factors associated with such an irregularity in PLWHA. A cross-sectional study of 
PLWHA who attended two referral centers in the city of Recife, in Northeastern Brazil, between June 2007 and October 2009 was 
carried out. The study analyzed socioeconomic factors, social service support and personal habits associated with nonadherence to 
antiretroviral therapy, adjusted by multivariable logistic regression analysis. The prevalence of PLWHA who reported irregular use 
of combination antiretroviral therapy (cART) was 25.7%. In the final multivariate model, the irregular use of cART was associated 
with the following variables: being aged less than 40 years (OR = 1.66, 95%-CI: 1.29-2.13), current smokers (OR = 1.76, 95%-CI: 
1.31-2.37) or former smokers (OR = 1.43, 95%-CI: 1.05-1.95), and crack cocaine users (OR = 2.79, 95%-CI: 1.24-6.32). Special 
measures should be directed towards each of the following groups: individuals aged less than 40 years, smokers, former smokers and 
crack cocaine users. Measures for giving up smoking and crack cocaine should be incorporated into HIV-control programs in order 
to promote greater adherence to antiretroviral drugs and thus improve the quality of life and prolong life expectancy.
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INTRODUCTION
Although the number of new HIV infections has declined globally 
by 19% over the past decade and the access to antiretroviral therapy in 
low- and middle-income countries has increased, HIV infection rates 
are increasing in several countries in Eastern Europe and central Asia, 
notably among injecting drug users and their sexual networks29. Access 
to antiretroviral treatment (ART) has been primarily responsible for 
prolonging and improving the lives of people living with HIV/AIDS 
(PLWHA), with Brazil, being the first developing country to implement 
the universal distribution of these drugs8,18. Consequently, nonadherence 
to the use of antiretroviral drugs is the greatest risk for a non-effective 
response to treatment and the possibility of spreading resistant viruses25,27. 
Moreover, poor adherence is one of the factors that may lead to a lower 
CD4 cell count, higher plasma viral RNA levels and delayed immune 
recovery, with progression of the disease that can lead to death11.
In the treatment of chronic disease, the degree of adherence is 
always influenced by a number of different factors: characteristics of the 
individual, characteristics of the disease, social support network (family 
and friends) and factors related to the health service, such as difficulties in 
accessing it, and the relationship of the health team/individual12. Amongst 
the characteristics of the individual, habits such as alcoholism, drug abuse 
and irregular use of antiretrovirals21place the individual at further risk of 
secondary infections. Furthermore, studies have shown that the quantity 
of pills is also an important factor that influences the rate of adherence8,11. 
For the treatment of HIV infection to be effective, several authors 
recommend an adherence level of at least 95% of the prescribed drugs to 
decrease the chance of viral resistance6. However, recent studies indicate 
that for boosted protease inhibitors an adherence level greater than 80% 
would be equally effective16.
Different methods have been employed in order to measure adherence 
to antiretrovirals, without a consensus gold standard. Due to their 
simplicity and the low costs involved, methods that use self-reports are 
widely used, and studies have demonstrated an association between the 
measure of self-reported adherence to antiretrovirals and HIV plasma 
viral load (with odds ratios and hazard ratios on the order of 2.0), making 
it possible to use this strategy in the conduct of PLWHA26,30.
The aim of this study was to identify the prevalence of the factors 
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associated with the irregular use of antiretroviral drugs in people living 
with HIV, with special emphasis on socioeconomic factors and life habits, 
intending thereby to identify the groups at greatest risk so as to develop 
new strategies that set out to minimize the problem.
METHODS
The study was conducted in Recife, a city in northeastern Brazil, with 
an estimated population of 1,561,659 inhabitants. This cross-sectional 
study was carried out in June 2007 and October 2009, with people 
living with HIV/AIDS aged 18 years and over, who attended two HIV 
referral centers in the state of Pernambuco (Hospital Correia Picanço and 
Hospital Universitário Oswaldo Cruz), which attend around 60% of the 
state’s patients. Individuals were invited to participate in the study either 
during routine consultations and/or hospitalization. Those who agreed 
to take part gave informed consent and were then interviewed by trained 
professionals who used a questionnaire developed specifically for this 
study. Hospitalized patients who could not answer the questionnaire due 
to their clinical condition were excluded from the study.
The dependent variable was the self-reported irregular use of 
combined antiretroviral therapy (cART), categorized in ‘yes’ - when 
patients reported a discontinuation of treatment at some point on their 
own - and ‘no’.
The independent variables were classified as: demographic (age and 
race), socioeconomics (marital status, social service support, head of 
household’s income), how long the patient has been aware of being HIV 
positive, life habits (alcoholism and drug abuse). Information regarding 
the use of cART was collected from medical records.
Users of illicit drugs (crack cocaine and cocaine) fell into the 
following categories: non-users; intermittent (intermittent users who had 
abstained during the past year) and current users (who had been using 
during the past year).
The criteria adopted for alcohol consumption was based on the 
number of drinks per day, according to the definition of alcohol 
consumption patterns approved by the Centers for Disease Control 
and Prevention (CDC)7. Patients were questioned about their alcohol 
consumption in the previous three months. Patients were classified as 
abstainers or light drinkers (non-drinkers or less than two drinks per day 
for men and one drink for women), and heavy drinkers (more than two 
drinks per day for men and more than one drink per day for women).
The Student’s t-test was used to compare the mean scores of the 
independent samples and variance was tested with Levene’s test. All 
variables associated with the irregular use of cART in the univariate 
analysis with a p-value of less than 0.20 were included in the 
multivariate analysis, using logistic regression and Odds Ratio (OR) 
with a confidence interval of 95%. The variables whose association 
with the event was statistically significant (p < 0.05) remained in the 
final multivariate model. The software used was Stata 11.2 (Stata-
Corp LP, College Station, TX). The study is part of a cohort, which 
has been carried out in two research centers, and was approved by the 
Ethics and Research Committee of the Centro de Ciências da Saúde 
da Universidade Federal de Pernambuco.
RESULTS
In the period from June 2007 to October 2009, 1815 PLWHA were 
interviewed, of which 1432 (78.9%) were taking cART. Of these, 52 
(3.6%) did not answer the question referring to the irregular use of 
treatment, and were therefore excluded from the study. The study sample 
was made up of 1380 patients with a mean age of 40.6 years (18-80) and 
a median age of 40.0 years; 64.1% were male and 79.1% had a monthly 
family income of less than two minimum wages. The majority (84.7%) 
lived in the metropolitan region of Recife. The prevalence of people who 
reported irregular use of cART was 25.7%. Among people who reported 
irregular use of cART, 42% had stopped taking the pills in the two weeks 
preceding the study interview.
A comparison of the mean ages, CD4 cell count and HIV viral load 
at the time of the interview revealed an association between self-reported 
irregular use of cART, being under 40 years old and a lower CD4 cell 
count (Table 1).
Table 1 shows the frequency distribution of the studied factors and the 
Table 1
Frequencies and univariate analysis of the association between characteristics of people living with HIV/AIDS and the irregular use of antiretroviral treatment, 
Recife, Pernambuco, Brazil, 2009
Irregular use of ART (case) Regular use of ART (control) Crude OR (CI) p
n % n %
Age
Years (mean) 38.8 41.3 0.001*
Age
≥ 40 years 157 21.39 577 78.61 1.0
< 40 years 198 30.65 448 69.35 1.62 (1.27 - 2.07) 0.000
Total 355 25.72 1025 74.28
Sex
Female 138 27.88 357 72.12 1.0
Male 217 24.52 668 75.48 0.84 (0.65 - 1.08) 0.171
Total 355 25.72 1025 74.28
BATISTA, J.D.L.; ALBUQUERQUE, M.F.P.M.; SANTOS, M.L.; MIRANDA-FILHO, D.B.; LACERDA, H.R.; MARUZA, M.; MOURA, L.V.; COIMBRA, I. & XIMENES, R.A.A. - Association 
between smoking crack cocaine abuse and the discontinuation of combination antiretroviral therapy in Recife, Pernambuco, Brazil. Rev. Inst. Med. Trop. Sao Paulo, 56(2): 127-32, 2014.
129
Irregular use of ART (case) Regular use of ART (control) Crude OR (CI) p
n % n %
Skin color
White 92 25.34 271 74.66 1.0
Non-white 263 25.86 754 74.14 1.03 (0.78 - 1.35) 0.847
Total 355 25.72 1025 74.28
Alcohol intake
Heavy drinker 225 23.61 728 76.39 1.0
Light drinker or abstainer 130 30.44 297 69.56 1.42 (1.10 - 1.83) 0.007
Total 355 25.72 1025 74.28
Smoking status
Never smoked 133 21.28 492 78.72 1.0
Former smoker 97 26.08 275 73.92 1.30 (0.97 - 1.76) 0.083
Current smoker 125 32.64 258 67.36 1.79 (1.34 - 2.39) 0.000
Total 355 25.72 1025 74.28
Use of cocaine
Never used 311 25.04 931 74.96 1.0
Intermittent users** 37 29.84 87 70.16 1.27 (0.85 - 1.91) 0.243
Current users 7 58.33 5 41.67 4.19 (1.32 - 13.3) 0.015
Total 355 25.76 1023 74.24
Use of crack
Never used 319 24.79 968 75.21 1.0
Intermittent users** 22 32.84 45 67.16 1.48 (0.88 - 2.51) 0.141
Current users 14 56.00 11 44.00 3.86 (1.73 - 8.59) 0.001
Total 355 25.74 1024 74.26
Can read and write
Yes 317 26.05 900 73.95 1.0
No 37 24.03 117 75.97 0.90 (0.61 - 1.33) 0.589
Total 354 25.82 1017 74.18
Monthly income of head of family
≥ 2 minimum wages 55 22.36 191 77.64 1.0
< 2 minimum wages 251 26.96 680 73.04 1.28 (0.92 - 1.79) 0.144
Total 306 26.00 871 74.00
Marital status
Married 64 22.38 222 77.62 1.0
Other*** 291 26.60 803 73.40 1.26 (0.92 - 1.71) 0.146
Total 355 25.72 1025 74.28
Social service support
Lives with family or partner 282 25.59 820 74.41 1.0
Lives alone or in a shelter 73 26.26 205 73.74 1.03 (0.77 - 1.39) 0.820
Total 355 25.72 1025 74.28
City of residence
Recife 148 26.86 403 73.14 1.0
Other 204 24.97 613 75.03 0.91 (0.71 - 1.16) 0.433
Total 352 25.73 1016 74.27
CD4 baseline
cells/mm3 (mean) 383.9 446.1 0.002*
Viral load baseline
copies/mL (mean) 29,501.7 18,114.7 0.198*
* Student’s t test; ** Users who have abstained during the past year; *** Separated, divorced, widowed or single.
Table 1 (continuation)
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result of the univariate analysis of the association with the self-reported 
irregular use of cART. 
Regarding the habits of the study population (Table 1), 69.1% were 
considered abstainers or light drinkers of alcoholic beverages; most 
participants had never used cocaine or crack cocaine (90.1% and 93.3% 
respectively); in relation to smoking, most individuals (54.7%) were 
current or former smokers, the majority (84.2%) having consumed 
cigarettes for 10 years or more.
In the multivariate analysis (Table 2), associations with the irregular 
use of cART in a statistically significant manner were, an age lower than 
or equal to 39 (p < 0.001), a former smoker (p = 0.023), currently smoking 
(p < 0.001) and currently using crack cocaine (p = 0.013). 
DISCUSSION
After adjusting the socioeconomic and social service support 
variables, the discontinuation of combination antiretroviral therapy was 
associated with the following variables: being aged less than 40 years, a 
former smoker or a current smoker and a crack cocaine user. 
The prevalence of people who reported irregular use of cART was 
25.7%. This prevalence was similar to the prevalence of non-adherence 
to treatment encountered in a number of studies in Brazil4,6,23,25. Most 
studies conclude that taking less than 90-95% of prescription drugs is an 
indication of non-adherence, unlike the present study, which evaluated 
individual patient responses to questions regarding the discontinuation 
of treatment at some point in time. Studies also show the importance 
of including additional resources to self-reporting, such as testing 
tablets, to provide a better evaluation of adherence22. Even without a 
consensus concerning the method of measuring this adherence, studies 
have indicated similar results of prevalence, demonstrating that the 
most appropriate method of certifying adherence to treatment was to 
question the patient directly. The strategy which uses, direct patient 
questioning, was chosen because it is easy to employ in everyday health 
care. We are aware that adherence may be overestimated due to a fear of 
displeasing the interviewer, the health professional or physician (false 
negative response); however those who actually report poor adherence 
are probably expressing the truth (decrease in false positive response) 
and are an important group to intervene with. The option for the question 
on abandonment of treatment at some point, without the restriction to a 
length time before and after the interview, aimed to expand the knowledge 
of the problem. We recognize that in the systematic care to the patient, 
the definition of a time span would be crucial in the evaluation of the 
patient’s response to treatment and in the selection of the best intervention 
to be adopted to change the patient’s behavior. It would also minimize 
recall bias.
Most of the patients from this study were male and had a low 
monthly family income. These factors were related to poor adherence 
to antiretroviral treatment in another study12. Low socioeconomic status 
may be a proxy of several factors associated to nonadherence, such 
as difficulties in accessing the health system, difficulties involved in 
understanding the individual regarding his/her health situation, etc.26. 
Since the research involved a very low socioeconomic population, the 
study of the association of characteristics such as lifestyle, with the 
irregular use of cART, may be more specific to define the individual 
at risk.
Research has indicated that older patients have a better adherence 
to antiretroviral treatment15, which also reinforces the findings of this 
study. It is possible that, due to a better perception of their own health, 
older people tend to better assimilate the importance of treatment and 
the consequences of interrupting it. This data was also encountered in 
another study undertaken in Brazil, where being younger was related to 
low adherence to the treatment5.
Being a former smoker or a current smoker was associated with 
the discontinuation of combination antiretroviral therapy. Cigarette 
smoking has been associated with sexual behavior and drug abuse1,13 
and with a lower inclination to develop healthy behaviors related to 
Table 2
Multivariate analysis of the association between characteristics of people living with HIV/AIDS and the irregular use of antiretroviral treatment, Recife, Pernambuco, 
Brazil, 2009
Crude OR OR adjusted by the multivariate
OR (CI) p OR (CI) p
Age
≥ 40 years 1.0 1.0
< 40 years 1.62 (1.27 - 2.07) 0.000 1.66 (1.29 - 2.13) 0.000
Smoking
Never smoked 1.0 1.0
Former smoker 1.30 (0.97 - 1.76) 0.083 1.43 (1.05 - 1.95) 0.023
Current smoker 1.79 (1.34 - 2.39) 0.000 1.76 (1.31 - 2.37) 0.000
Use of crack
Never used 1.0 1.0
Intermittent users* 1.48 (0.88 - 2.51) 0.141 1.20 (0.70 - 2.06) 0.501
Current users 3.86 (1.73 - 8.59) 0.001 2.79 (1.24 - 6.32) 0.013
* Users who have abstained during the past year.
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diet17,20 and physical activity17. The same mechanism that predisposes 
all these behaviors may also lie behind, associated or not with these 
factors, a behavior less prone to adhere to medication. A study carried 
out by our group, in a cohort of people living with HIV/AIDS and under 
tuberculosis treatment, showed an association between smoking and the 
evasion of tuberculosis treatment19. The present study corroborates the 
findings of other authors who found an association between smoking and 
lower adherence to antiretrovirals4,24, either smoking alone or as part of 
a risky behavior profile. Depression has been thought of as a possible 
mediator between smoking and adherence to antiretrovirals28 but this is 
not a finding common to all authors4.
People who use drugs tend to be more socially vulnerable and have 
a chaotic, unstable lifestyle that influences the adherence to any type of 
chronic treatment8. The use of illicit drugs has been associated with both 
nonadherence and a decrease in the viral and immunologic responses 
to antiretrovirals18, the former also being a finding in the present study. 
Research has demonstrated that cocaine (including the crack variation) 
has an influence over the pathogenesis of AIDS, accelerating its 
progression and the risk of mortality, morbidity and an increased viral 
load9,10. For this group, an increase in the viral load may be related to 
nonadherence to the treatment, which may lead to viral resistance and 
subsequently to an immunological decline, thus favoring the HIV virus 
and its replication. 
Studies show that direct administered antiretroviral therapy (DAART) 
in people living with HIV/AIDS who use drugs may improve adherence 
and thus improve the immune status of the individual2,3. Beyond DAART, 
other interventions such as counseling by motivational interviewing or 
video information, which is feasible in health care centers, improve 
adherence to antiretroviral treatment and maintain their efficacy three 
months later14.
Once adherence to treatment has been promoted through individual 
approaches and discussions by health professionals in the majority of the 
specialized services for treating PLWHA, differentiated attention towards 
smokers and crack users, as well as interaction with specific control 
programs, are central to good adherence to antiretroviral treatment and 
the consequent reduction of viral resistance.
This study has some constraints. We are aware that the strategy used 
to measure the use of illicit substances may not be very accurate as a 
participant who has experienced crack cocaine once in the previous 12 
months, an occasional user and a drug dependent (who used crack cocaine 
in the same time span), are all classified as current users of crack cocaine, 
although usage patterns and possibly behavior differ. The constraint posed 
to the interpretation of our findings by the discontinuation of combination 
antiretroviral therapy being measured has already been mentioned. 
Finally, a major limitation of this study, because of its cross-sectional 
design, is that it is not possible to establish the temporal sequence between 
exposure and outcome and differentiate cause and effect. Nevertheless 
the results pointed to groups which should be monitored differentially 
because of their association with discontinuation of combination 
antiretroviral therapy.
Further studies, using a longitudinal design and more restricted 
definitions, could complement our findings.
RESUMO
Associação entre tabagismo e o uso de crack com a 
descontinuidade da terapia antirretroviral combinada em Recife, 
Pernambuco, Brasil
Apesar da eficácia da terapêutica antirretroviral combinada para 
o tratamento de pessoas vivendo com HIV/Aids, a não adesão aos 
medicamentos tem se tornado uma das maiores ameaças à efetividade 
dessa terapêutica. O objetivo desse estudo foi estimar a prevalência de uso 
irregular autorreferido da terapia antirretroviral e os fatores associados 
com essa irregularidade em pessoas vivendo com HIV. Foi realizado 
um estudo seccional de pessoas vivendo com HIV/Aids atendidas em 
dois centros de referência no Recife, Nordeste do Brasil, entre junho 
2007 e outubro de 2009. Foram analisados os fatores socioeconômicos, 
de apoio social e de hábitos do indivíduo, ajustados através de análise 
de regressão logística multivariada. A prevalência de pessoas vivendo 
com HIV/Aids que relataram o uso irregular da terapia antirretroviral 
combinada (TARC) foi de 25,7%. No modelo multivariado final, o uso 
irregular da TARC esteve associado às seguintes variáveis: ter menos de 
40 anos (OR = 1,66, IC95%: 1,29-2,13), fumantes (OR = 1,76, IC95%: 
1,31-2,37) ou ex-fumantes (OR = 1,43, IC95%: 1,05-1,95) e ser usuário 
de crack (OR = 2,79, IC95%: 1,24-6,32). Medidas especiais devem ser 
direcionadas para cada um dos seguintes grupos: adultos com menos de 
40 anos, fumantes, ex-fumantes e usuários de crack. Ações voltadas para 
a cessação do tabagismo e do crack devem ser incorporadas ao programa 
de controle dos infectados pelo HIV, visando promover a maior adesão 
aos antirretrovirais e, consequentemente, aumentar a expectativa e a 
qualidade de vida.
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